| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Girshick Birgit | Corporate Executive VP & COO | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ Birgit Girshick | 02 Jun 2025 | 0001732091 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | $1,659,976 | +12,239 | +23% | $135.63 | 66,227 | 30 May 2025 | Direct | F1 |
| transaction | CRL | Common Stock | Tax liability | $38,383 | -283 | -0.43% | $135.63 | 65,944 | 31 May 2025 | Direct |
| Id | Content |
|---|---|
| F1 | Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029. |